Home
>
National Drug Code (NDC)
>
Cinryze
Cinryze - 42227-081-05 - (HUMAN C1-ESTERASE INHIBITOR)
Drug Information of Cinryze
| Product NDC: | 42227-081 |
| Proprietary Name: | Cinryze |
| Non Proprietary Name: | HUMAN C1-ESTERASE INHIBITOR |
| Active Ingredient(s): | 500 [iU]/5mL & nbsp; HUMAN C1-ESTERASE INHIBITOR |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cinryze
| Product NDC: | 42227-081 |
| Labeler Name: | ViroPharma Biologics |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125267 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20081201 |
Package Information of Cinryze
| Package NDC: | 42227-081-05 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (42227-081-05) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Information of Cinryze
| NDC Code | 42227-081-05 |
| Proprietary Name | Cinryze |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (42227-081-05) > 5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 42227-081 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | HUMAN C1-ESTERASE INHIBITOR |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20081201 |
| Marketing Category Name | BLA |
| Labeler Name | ViroPharma Biologics |
| Substance Name | HUMAN C1-ESTERASE INHIBITOR |
| Strength Number | 500 |
| Strength Unit | [iU]/5mL |
| Pharmaceutical Classes | Human C1 Esterase Inhibitor [EPC],Decreased Vascular Permeability [PE],Kallikrein Inhibitors [MoA] |
